|
Mutation Information
|
Mutation Site
|
T66I |
|
Mutation Type
|
Amino acid level |
|
Gene/Protein/Region Type
|
IN |
|
Relevant Drug
|
rilpivirine (RPV) |
|
Country
|
Austria |
Literature Information
|
PubMed PMID
|
31915716
|
|
Disease
|
HIV infection/AIDS
|
|
Published Year
|
2020 |
|
Journal
|
Open forum infectious diseases |
|
Title
|
Antiretroviral Treatment Simplification With 2-Drug Regimens: Impact of Transmitted Drug Resistance Mutations. |
|
Author
|
Kessler HH,Stelzl E,Blažič A,Mehta SR,Benezeder AS,Genger-Hackl C,Santner BI,Chaillon A,Hoenigl M |
|
Evidence
|
Of 192 individuals, 1 (0.5%) showed resistance (a combination of T66I and T97A) against DTG. Eight (4.2%) patients harbored any DRM against 3TC.
|
|
|
HIV Mutation Detail Information